Encorafenib Impurity 7 | CAS 1269440-58-5 - Request Quote
Encorafenib Impurity 7
| SZ CAT No: | SZ-E056010 |
| CAS No | 1269440-58-5 |
| Mol.F. | C10H10ClIN4 |
| Mol.Wt. | 348.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Encorafenib Impurity 7 is chemically 2-Chloro-4-(3-iodo-1-isopropyl-1H-pyrazol-4-yl)pyrimidine. Encorafenib Impurity 7 is supplied with detailed characterization data compliant with regulatory guideline. Encorafenib Impurity 7 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Encorafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1269440-58-5
Purchase 1269440-58-5
Order 1269440-58-5
Enquire 1269440-58-5
price of 1269440-58-5
1269440-58-5 Supplier
1269440-58-5 Manufacturer
1269440-58-5 Exporter
buy high quality Encorafenib Impurity 7
Purchase Encorafenib Impurity 7
Encorafenib Impurity 7 suppliers
Encorafenib Impurity 7 manufacturers
Encorafenib Impurity 7 price
Order Encorafenib Impurity 7
Enquire Encorafenib Impurity 7
Encorafenib Impurity 7 cost
Encorafenib Impurity 7 Supplier
Encorafenib Impurity 7 Distributor
Encorafenib Impurity 7 for Method Validation
Encorafenib Reference Standard
Encorafenib Impurity 7 for ANDA Filing
Encorafenib Impurity 7 for Forced Degradation Studies
Encorafenib Impurity 7 Identification Standards
Encorafenib Impurity 7 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.